title: Does the timing of treatment affect the ocular phenotype in patients with Mucopolysaccharidosis I homozygous for the L490P mutation?
authors.affiliation: Kettering General Hospital, Northamptonshire, UK.
authors.forename: W H
authors.initials: WH
authors.lastname: Chan
authors.forename: S
authors.initials: S
authors.lastname: Biswas
authors.forename: I C
authors.initials: IC
authors.lastname: Lloyd
authors.forename: E
authors.initials: E
authors.lastname: Wraith
authors.forename: S
authors.initials: S
authors.lastname: Jones
authors.forename: J
authors.initials: J
authors.lastname: Mercer
authors.forename: J L
authors.initials: JL
authors.lastname: Ashworth
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D056947:Enzyme Replacement Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D008297:Male; D008059:Mucopolysaccharidosis I / Q000235:genetics / Q000628:therapy*; D010641:Phenotype; D013997:Time Factors